These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10899090)

  • 1. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.
    Varani K; Portaluppi F; Gessi S; Merighi S; Ongini E; Belardinelli L; Borea PA
    Circulation; 2000 Jul; 102(3):285-9. PubMed ID: 10899090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine alters A2A adenosine receptors and their function in human platelets.
    Varani K; Portaluppi F; Merighi S; Ongini E; Belardinelli L; Borea PA
    Circulation; 1999 May; 99(19):2499-502. PubMed ID: 10330379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
    Feoktistov I; Biaggioni I
    Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
    Phelps PT; Anthes JC; Correll CC
    Eur J Pharmacol; 2006 Apr; 536(1-2):28-37. PubMed ID: 16581066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus.
    Polak D; Talar M; Wolska N; Wojkowska DW; Karolczak K; Kramkowski K; Bonda TA; Watala C; Przygodzki T
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors.
    Varani K; Portaluppi F; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Dalpiaz A; Bortolotti F; Belardinelli L; Borea PA
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2350-8. PubMed ID: 16143823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
    J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes.
    Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA
    Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling via A2A adenosine receptor in four PC12 cell clones.
    Arslan G; Kull B; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):28-32. PubMed ID: 9933147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
    Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
    Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects.
    El-Hashim AZ; Abduo HT; Rachid OM; Luqmani YA; Al Ayadhy BY; Alkhaledi GM
    Pulm Pharmacol Ther; 2009 Jun; 22(3):243-52. PubMed ID: 19146972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery.
    Diniz C; Fresco P; Leal S; Gonçalves J
    Eur J Pharmacol; 2004 Nov; 504(1-2):17-25. PubMed ID: 15507216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A galpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor.
    Mazzoni MR; Taddei S; Giusti L; Rovero P; Galoppini C; D'Ursi A; Albrizio S; Triolo A; Novellino E; Greco G; Lucacchini A; Hamm HE
    Mol Pharmacol; 2000 Jul; 58(1):226-36. PubMed ID: 10860945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.
    El Yacoubi M; Ledent C; Ménard JF; Parmentier M; Costentin J; Vaugeois JM
    Br J Pharmacol; 2000 Apr; 129(7):1465-73. PubMed ID: 10742303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different microscopy approaches to quantification of inhibitory effect on thrombus formation under flow conditions by the example of adenosine receptor agonist HE-NECA.
    Przygodzki T; Wolska N; Talar M; Polak D; Gapinska M; Watala C
    J Pharmacol Toxicol Methods; 2018; 94(Pt 1):94-104. PubMed ID: 30031827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
    Cooper JA; Hill SJ; Alexander SP; Rubin PC; Horn EH
    Br J Clin Pharmacol; 1995 Jul; 40(1):43-50. PubMed ID: 8527267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.